Mrs Teresa B Taylor, MA, | |
720 Energy Center Blvd Ste 502, Northport, AL 35473-2794 | |
(205) 344-5507 | |
Not Available |
Full Name | Mrs Teresa B Taylor |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 720 Energy Center Blvd Ste 502, Northport, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164868766 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | C1591A (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Teresa B Taylor, MA, 720 Energy Center Blvd Ste 502, Northport, AL 35473-2794 Ph: (205) 344-5507 | Mrs Teresa B Taylor, MA, 720 Energy Center Blvd Ste 502, Northport, AL 35473-2794 Ph: (205) 344-5507 |
News Archive
ViroPharma Incorporated today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion at its plenary meeting in March 2011 recommending approval of a Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
A small antibody fragment that is highly effective in neutralizing the human immunodeficiency virus (HIV) by preventing the virus from entering cells has been identified by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).
Although sedatives are often administered before surgery, a randomized trial finds that among patients undergoing elective surgery under general anesthesia, receiving the sedative lorazepam before surgery, compared with placebo or no premedication, did not improve the self-reported patient experience the day after surgery, but was associated with longer time till removal off a breathing tube (extubation) and a lower rate of early cognitive recovery, according to a study in the March 3 issue of JAMA.
› Verified 9 days ago
Angela Shelton Chandler, Counselor Medicare: Not Enrolled in Medicare Practice Location: 307 Main Ave, Northport, AL 35476 Phone: 205-586-0584 | |
Mrs. Maria Gurganus, M.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 4124 Watermelon Rd Ste B, Northport, AL 35473 Phone: 205-454-1897 | |
Leah Parker, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 515 Energy Center Blvd, Northport, AL 35473 Phone: 205-750-0227 | |
Ashley Marie Neuhauser, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 Energy Center Blvd Ste 502, Northport, AL 35473 Phone: 205-499-6623 | |
Mrs. Sonya W Guy, LPC, CEAP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1905 4th St Ste 4, Northport, AL 35476 Phone: 205-632-5067 | |
Andrea Denice Gregg Whitten, LPC-S Counselor Medicare: Not Enrolled in Medicare Practice Location: 4124 Watermelon Rd Ste B, Northport, AL 35473 Phone: 205-454-1897 | |
Melissa Brooke Nippert, LPC-S Counselor Medicare: Not Enrolled in Medicare Practice Location: 800 Energy Center Blvd Apt 1106, Northport, AL 35473 Phone: 205-454-9762 |